This one's for Charles, I know she is reading.

"Cumberland Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration (FDA) has extended its review of the supplemental new drug application (sNDA) for the use of Acetadote? (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure."

Cumberland Pharmaceuticals Inc. said Friday the Food and Drug Administration extended its review of Acetadote as a treatment for patients with non-acetaminophen acute liver failure.

I heard about this and just found this story.

"NASHVILLE, Tenn., Aug. 20 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the U.S. Food and Drug Administration (FDA) has extended its review of the supplemental new drug application (sNDA) for the use of Acetadote? (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. The review has been extended by three months resulting in ..."